Product Code: ETC5634707 | Publication Date: Nov 2023 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
Israel plays a crucial role in the early diagnosis and management of cardiovascular diseases. With a growing aging population and increasing prevalence of lifestyle-related health conditions, there is a rising demand for cardiac marker testing solutions. Companies in the healthcare sector are leveraging technological advancements to develop innovative diagnostic tools and improve patient outcomes.
The Israel Cardiac Marker Testing Market is witnessing steady growth due to the increasing prevalence of cardiovascular diseases and the rising demand for early and accurate diagnostic tests. Cardiac marker tests are used for the diagnosis and prognosis of acute coronary syndrome, myocardial infarction, and heart failure. Moreover, technological advancements in cardiac marker testing methods, such as high-sensitivity assays and point-of-care testing devices, are driving market expansion. Additionally, strategic collaborations between diagnostic laboratories, hospitals, and research institutions are fostering innovation and accelerating market growth in Israel.
In the cardiac marker testing market, challenges include the high cost of diagnostic tests, limited access to advanced testing facilities in remote areas, and the need for continuous medical education to enhance diagnostic accuracy. Moreover, regulatory requirements for approval and reimbursement of cardiac marker tests add complexity to market entry for new players. Collaboration between healthcare providers, diagnostic laboratories, and technology developers is crucial for overcoming these challenges and improving patient outcomes.
The cardiac marker testing market in Israel is driven by the increasing prevalence of cardiovascular diseases and the growing adoption of point-of-care testing solutions. The Israel government prioritizes public health through investment in healthcare infrastructure, disease prevention programs, and medical research. Regulations and guidelines for clinical diagnostics ensure the accuracy and reliability of cardiac marker tests, promoting their widespread use in hospitals, clinics, and laboratories. Moreover, the government supports innovation in diagnostic technologies through funding for research and development projects. Policies promoting universal healthcare coverage and patient access to medical services contribute to the growth of the cardiac marker testing market in Israel.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cardiac Marker Testing Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cardiac Marker Testing Market - Industry Life Cycle |
3.4 Israel Cardiac Marker Testing Market - Porter's Five Forces |
3.5 Israel Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.7 Israel Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Israel Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Cardiac Marker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Cardiac Marker Testing Market Trends |
6 Israel Cardiac Marker Testing Market Segmentations |
6.1 Israel Cardiac Marker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F |
6.1.3 Israel Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F |
6.2 Israel Cardiac Marker Testing Market, By Biomarker Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F |
6.2.3 Israel Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F |
6.2.4 Israel Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F |
6.2.5 Israel Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F |
6.2.6 Israel Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F |
6.2.7 Israel Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F |
6.3 Israel Cardiac Marker Testing Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 Israel Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F |
6.3.3 Israel Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F |
6.3.4 Israel Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F |
6.3.5 Israel Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F |
6.3.6 Israel Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F |
6.4 Israel Cardiac Marker Testing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F |
6.4.3 Israel Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F |
6.4.4 Israel Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F |
7 Israel Cardiac Marker Testing Market Import-Export Trade Statistics |
7.1 Israel Cardiac Marker Testing Market Export to Major Countries |
7.2 Israel Cardiac Marker Testing Market Imports from Major Countries |
8 Israel Cardiac Marker Testing Market Key Performance Indicators |
9 Israel Cardiac Marker Testing Market - Opportunity Assessment |
9.1 Israel Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.3 Israel Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 Israel Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Cardiac Marker Testing Market - Competitive Landscape |
10.1 Israel Cardiac Marker Testing Market Revenue Share, By Companies, 2024 |
10.2 Israel Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |